ERBB2 and neoplasm: One example of this complexity is the synergistic effect between HER2 activation and estrogen-driven tumor growth: HER2 amplification can enhance estrogen’s proliferative effects, which may undermine traditional anti-estrogen therapies, as these treatments can inadvertently intensify HER2-mediated signaling.